Mauna Kea (MKEAF) 2.3500 $MKEAF Mauna Kea Technologies

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Mauna Kea (MKEAF) 2.3500 $MKEAF

Mauna Kea Technologies Announces Its 2016 Financial Calendar
PR Newswire - Mon Dec 21, 1:00AM CST
Mauna Kea Technologies (Euronext: MKEA, FR0010609263), inventor of Cellvizio®, the multidisciplinary confocal laser endomicroscopy platform, announced today its schedule for the publication of financial information for 2016.

Mauna Kea Technologies and Cook Medical Enter Into a Global Multi-year Commercialization Partnership for Endomicroscopy in Urology
PR Newswire - Thu Dec 10, 12:43PM CST
-- Cook Medical will commercialize a private-labeled version of Cellvizio for urologic applications

Mauna Kea Technologies Receives New Regulatory Approval for Cellvizio 100s in China
PR Newswire - Tue Dec 08, 11:26AM CST
-- Green light for expanded use of Cellvizio in China into pancreatic and urologic applications with the clearance of associated miniprobes

Mauna Kea Technologies Awarded U.S. FDA Clearance for use of Cellvizio in Minimally Invasive Surgery
PR Newswire - Tue Oct 27, 11:45AM CDT
MAUNA KEA TECHNOLOGIES AWARDED U.S. FDA CLEARANCE FOR USE OF CELLVIZIO IN MINIMALLY INVASIVE SURGERY

New Publication Confirms Important Role of Needle-Based Endomicroscopy for the Characterization of Pancreatic Cysts
PR Newswire - Wed Oct 21, 11:00AM CDT
Mauna Kea Technologies (Euronext: MKEA, FR0010609263, PEA-PME eligible), inventor of Cellvizio®, the multidisciplinary confocal laser endomicroscopy platform, today announced that the peer-reviewed journal Surgical Endoscopy has released a new article highlighting the advantages of needle-based confocal laser endomicroscopy (nCLE) for characterization of different types of pancreatic cysts.

Mauna Kea Technologies Announces 2015 Third Quarter Sales
PR Newswire - Thu Oct 15, 11:22AM CDT
Mauna Kea Technologies (Euronext: MKEA, FR0010609263, PEA-PME eligible), inventor of Cellvizio®, the multidisciplinary confocal laser endomicroscopy platform, today announced its sales for the quarter ended September 30, 2015 and the first nine months of 2015.

Flexible Endoscopes Pipeline Review, 2015 - Extensive Coverage of the Flexible Endoscope Products Under Development
M2 - Mon Aug 17, 9:19AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4j9w5v/flexible) has announced the addition of the "Flexible Endoscopes - Pipeline Review, 2015" report to their offering. Summary This Medical Devices sector report, Flexible Endoscopes - Pipeline Review, 2015" provides an overview of Flexible Endoscopes currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Flexible Endoscope pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by Our team of industry experts. Scope - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The report reviews the major players involved in the development of Flexible Endoscopes and list all their pipeline projects - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage - The report provides key clinical trial data of ongoing trials specific to pipeline products - Recent developments in the segment / industry Key Topics Covered: 1 List of Tables and List of Figures 2 Introduction 3 Products under Development 4 Flexible Endoscopes - Pipeline Products under Development by Companies 5 Flexible Endoscopes Companies and Product Overview 6 Flexible Endoscopes- Recent Developments Companies Mentioned - Boston TransTec, LLC - Cornell University - Endogene Ltd - Fraunhofer-Institut fur Integrierte Schaltungen - GI-View Ltd. - Imperial College London - Inmotion Medical Ltd. - Kaleidoscope - LightScan Technologies, Inc. - Mauna Kea Technologies SAS - Medigus Ltd. - Medrobotics Corporation - National Cheng-Kung University Hospital - Olympus America, Inc. - Optiscan Imaging Limited - SMART Medical Systems Ltd. - Universitat Politecnica de Catalunya - University of East Anglia - University of Texas at Austin - Vanderbilt University - Vision-Sciences, Inc. For more information visit http://www.researchandmarkets.com/research/4j9w5v/flexible
MDGS: 1.69 (+0.02)

Mauna Kea Technologies Receives Regulatory Approval for the AQ-Flex 19 Miniprobe in Japan
PR Newswire - Mon Jul 06, 12:00PM CDT
Mauna Kea Technologies (Euronext: MKEA, FR0010609263), inventor of Cellvizio®, the multidisciplinary confocal laser endomicroscopy platform, announced today it has obtained approval from Japan's Ministry of Health, Labor and Welfare (MHLW) for its unique needle-base Confocal Laser Endomicroscopy solution, the AQ-Flex 19 miniprobe.

Mauna Kea Technologies Announces CE Mark for use of Cellvizio® During Interventional Radiology Procedures
PR Newswire - Tue Jun 09, 12:17PM CDT
-- Key regulatory and product development milestone on the company's application roadmap

Mauna Kea Technologies Announces CE Mark for Use of Cellvizio® in Minimally Invasive Surgery
PR Newswire - Mon May 18, 12:04PM CDT
Mauna Kea Technologies (Euronext: MKEA, FR0010609263), inventor of Cellvizio®, the multidisciplinary confocal laser endomicroscopy platform, announced today CE mark for the use of Cellvizio in minimally invasive laparoscopic surgical indications. This regulatory milestone positions Cellvizio for useful imaging support in a wide range of oncologic surgical procedures, many of which have already been investigated successfully in several clinical studies throughout Europe.

Mauna Kea Technologies Obtains Regulatory Approval for the Commercialization of Cellvizio® in Mexico
PR Newswire - Mon Apr 20, 11:42AM CDT
-- Mexico is the second largest medical device market in Latin America after Brazil

Mauna Kea Technologies Reports Record Attendance at ICCU 2015 and at the Associated Post-graduate Course on Endomicroscopy
PR Newswire - Wed Apr 15, 11:00AM CDT
-- 300 physicians and surgeons gathered in Lisbon at the International Conference of Cellvizio Users to discuss advancements and benefits of endomicroscopy in multiple medical and surgical indications

Grenoble University Hospital First Hospital in France to set up a Multidisciplinary Optical Biopsy Program With the Cellvizio Endomicroscopy Platform
PR Newswire - Tue Mar 31, 12:21PM CDT
Mauna Kea Technologies (Euronext: MKEA, FR0010609263), inventor of Cellvizio®, the multidisciplinary confocal laser endomicroscopy platform, today announced the set-up of an optical biopsy program at the CHU de Grenoble (university hospital center). The CHU de Grenoble is now the first hospital in France to propose to its gastroenterology, interventional pulmonology and urology patients an innovative platform for clinical research and a higher standard of care thanks to the endomicroscopy technology developed by Mauna Kea Technologies.

Mauna Kea Technologies Announces Publication of Confirmation Data on the Value of Endomicroscopy for the Characterization of Pancreatic Cystic Neoplasms
PR Newswire - Wed Mar 25, 12:00PM CDT
Investigator-Initiated DETECT Study shows benefits of using Cellvizio to safely differentiate the nature of pancreas cysts with high specificity and accuracy

Baptist Medical Center in Florida Adopts Endomicroscopy with Cellvizio to Improve Care for Patients with Biliary and Pancreatic Diseases
PR Newswire - Mon Mar 23, 2:03PM CDT
Mauna Kea Technologies (Euronext: MKEA, FR0010609263), inventor of Cellvizio®, the multidisciplinary confocal laser endomicroscopy platform, today announced that Baptist Medical Center in Jacksonville, Florida, a leading medical center in the southeastern United States, has adopted the Cellvizio technology platform to perform enhanced procedures in the field of biliary and pancreatic disorders including probe-based confocal laser endomicroscopy (pCLE) and needle-based confocal laser endomicroscopy (nCLE).

Leading 100 Medical Devices/Technology/Supplies Companies of Europe 2015
M2 - Mon Mar 23, 10:17AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wfwcrh/europe_medical) has announced the addition of the "Europe Medical Devices/Technology/Supplies 100: An Industry Report" report to their offering. Medical technology aims to improve the quality of healthcare provided. Recent advances in this industry globally are focusing on cost reduction, less-invasive treatment options, and reduction in hospital stays and rehabilitation process. Medical technology is a key driver for Europe's economic well-being, providing quality employment, and a substantial contribution to Europe's balance of trade. The European medical technology market is estimated at roughly 100 billion and is the second largest medical technology market after US. It has been growing on average by 4% per annum over the past 6 years. Through its healthcare innovations, the European medical device industry contributes to ensuring sustainable and accessible healthcare systems throughout Europe. With this special industry report, our endeavor is to provide the new investors globally with a complete resourceful research report for familiarizing with the present investment trends of the European companies in the medical industry, which they would find beneficial to pursue for making business decisions in this sector. Report Highlights: - Leading 100 medical devices/technology/supplies companies of Europe - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances among European medical devices/technology/supplies companies - International presence of European medical devices/technology/supplies companies - R&D activities by European medical devices/technology/supplies companies Report Includes Companies Engaged in: - Manufacturing medical equipments providing any medical activity and/or treatment - Manufacturing diagnostic equipments - Manufacturing high-tech medical instruments - Manufacturing life-support medical equipments - Manufacturing research instruments and scientific analytical equipment - Providing software for improving treatments - Providing medical information technology - Manufacturing medical bio-tech products - Providing value-based healthcare services - Manufacturing molecular diagnostic instruments - Manufacturing pacemakers, imaging instruments, dialysis machines and implants, hip and knee replacement medical devices, heart stents, thermal cyclers and mass spectrometers, microarrays and other similar products - Manufacturing and/or selling basic medical and surgical materials (consumables), low-tech items and items used in medical equipment processor or for treating patients - Diagnostic equipment supplies - Medical supplies invasive and medical supplies non invasive - Manufacturing/supplying replaceable lenses for equipments - Manufacturing/supplying any item which needs to be replaced as a function of repeated medical activity or where need for treatments is constant - Manufacturing/supplying surgical and dental instruments, elective laser surgery equipments, orthopedic products, and other such products Companies Mentioned - Ion Beam Applications SA (Belgium) - Kitron ASA (Norway) - LiDCO Group PLC (United Kingdom) - MagForce AG (Germany) - Mauna Kea Technologies SAS (France) - Medica AD Sofia (Bulgaria) - Medicrea International (France) - Medisana AG (Germany) - Mercator Medical SA (Poland) - Nobel Biocare Holding AG (Switzerland) - Omega Diagnostics Group Plc (United Kingdom) - Orthofix International N.V. (Netherlands Antilles) - PuriCore PLC (United Kingdom) - PZ Cormay SA (Poland) - Sorin SpA (Italy) - Stentys (France) - Surgical Innovations Group PLC (United Kingdom) - Technoflex SA (France) - Voxel S.A. (Poland) For more information visit http://www.researchandmarkets.com/research/wf...pe_medical
OFIX: 42.42 (+0.13)

Mauna Kea Technologies Receives Additional CPT® Reimbursement Code in the U.S. Supporting Key Application of Endomicroscopy with Cellvizio in the Biliary Tract
PR Newswire - Tue Mar 17, 1:02PM CDT
Mauna Kea Technologies (Euronext: MKEA, FR0010609263), inventor of Cellvizio®, the multidisciplinary confocal laser endomicroscopy platform, today announced that the American Medical Association (AMA) Editorial Panel has awarded a new CPT Code related to the use of endomicroscopy during endoscopic retrograde cholangiopancreatography (ERCP) procedures to enable physicians to diagnose health problems in the biliary tract including diagnosis of biliary strictures and the presence of biliary cancer. More than 500,000 ECRPs are completed annually in the United States.

Mauna Kea Technologies Announces Acceleration of Installations and Use of Cellvizio Endomicroscopy Platform in Japan
PR Newswire - Wed Mar 11, 6:46PM CDT
Technology highlighted in first-ever Japanese live demonstration during the 14th Yokohama International Endoscopy Conference.

Mauna Kea Technologies Announces Publication of Consensus Report Based on Clinical Evidence on Use of Confocal Laser Endomicroscopy in Gastroenterology
PR Newswire - Tue Jan 20, 10:45AM CST
Mauna Kea Technologies (Euronext: MKEA, FR0010609263), inventor of Cellvizio®, the multidisciplinary confocal laser endomicroscopy platform, today announced publication of the first consensus recommendations on the clinical use of probe-based confocal laser endomicroscopy (pCLE) in gastrointestinal applications, by the peer-reviewed journal United European Gastroenterology. The recommendations were presented in an article entitled: "Use of probe-based confocal laser endomicroscopy (pCLE) in gastrointestinal applications: a consensus report based on clinical evidence", authored by 26 international experts in gastroenterology and confocal laser endomicroscopy.

Mauna Kea Technologies: Editorial Highlighting Advantages of Needle-based Endomicroscopy for Characterization of Pancreatic Cysts Published in Endoscopy
PR Newswire - Wed Jan 14, 11:30AM CST
-- Editorial accompanies publication of CONTACT 1 Study results showing that needle-based confocal laser endomicroscopy with Cellvizio able to confirm benign serous cystadenomas with 100% specificity.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 323

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 259

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 297

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 609

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 354

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 423

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 411

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 258

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
UAE Ties Diplomacy, Media and AI Into a Shared Signal

Updated Category News Views 128

Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...

Continue Reading
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 494

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading

Top 5 Most Recently Viewed Articles

Unisync Triumphs at NAUMD Awards, Showcasing Innovation and Leadership

Updated Category News Views 181

Unisync Celebrates Major Recognition at NAUMD Awards Unisync Corp. (TSX: UNI) is thrilled to announce its recent achievements at the esteemed NAUMD (Network Association of Uniform Manufacturers and Distributors) Annual Convention, where it received four significant awards, showcasing its commitment to excellence in the managed uniform services industry. This remarkable...

Continue Reading
Key Economic Insights: Fed Chair Prospects and Global Data Releases

Updated Category News Views 264

Key Economic Insights for the Week Ahead The upcoming week presents a wealth of important economic information and events that could shape market expectations and financial strategies. From Federal Reserve leadership changes to significant global economic indicators, here’s what to anticipate. Potential Fed Chair Nomination With the resignation of the current Fed Chair...

Continue Reading
Understanding Investor Sentiments Surrounding AST SpaceMobile

Updated Category News Views 353

Investor Sentiment Towards AST SpaceMobile AST SpaceMobile (NYSE: ASTS) has seen a notable change in its short interest recently, with a decrease of 3.58% reported. This highlights a shift in investor sentiment, emphasizing how the market views the telecommunications innovator. Currently, approximately 45.07 million shares have been sold short, representing 20.75% of the...

Continue Reading
Insights into NuScale Power's Market Position and Trends

Updated Category News Views 163

Understanding NuScale Power's Market Sentiment NuScale Power (NYSE: SMR) has experienced notable changes in its short interest recently. The latest report indicates that the short percent of float has decreased by 6.75%, showcasing a decline in bearish sentiment towards the company. Currently, 26.80 million shares have been sold short, translating to 20.16% of all regular...

Continue Reading
BTQ Technologies and QBits Unveil Quantum-Secure Custody Infrastructure

Updated Category News Views 226

BTQ Technologies and QBits Launch Groundbreaking Initiative BTQ Technologies, in collaboration with QBits, is set to revolutionize the digital asset landscape with the development of the world's first quantum-secure custody treasury infrastructure. This partnership aims to leverage the innovative capabilities of the Quantum Canary Network, which will act as a public...

Continue Reading